Artificial Tears: Market Research Report

January 2019 | 143 pages | ID: A266C8DAFF7EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Artificial Tears in US$ Thousand.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024.

Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs. The report profiles 49 companies including many key and niche players such as -

• Allergan, Inc.
• Akorn, Inc.
• Bausch & Lomb Incorporated
• Johnson & Johnson
• Novartis International AG
• Santen Pharmaceuticals Co, Ltd.

Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

2. INDUSTRY OVERVIEW

Dry Eyes – A Lucrative Segment of Ophthalmology Market

Table 1. Global Ophthalmology Market (2017): Percentage Share Breakdown by Product Segment (includes corresponding Graph/Chart)

Artificial Tears: The First Line and Mainstay Treatment for Dry Eyes

Table 2. Global Dry Eye Treatment Market (2017): Percentage Share Breakdown of Revenues by Over-the-Counter and Rx Segments (includes corresponding Graph/Chart)

Other Therapies for Dry Eye
Current & Future Analysis
Developing Countries Display Strong Growth Prospects
Under-reporting of DES Condition Stifles Market Opportunities
Prevalence and Incidence of Dry Eye Syndrome

Table 3. Prevalence of Dry Eye Syndrome Across Select Countries (in %) (includes corresponding Graph/Chart)

Select Stats on Prevalence Rates
Concentrated Prescription Dry Eye Products Market Benefits OTC Market
Multi-Factorial Nature of Dry Eye Poses Challenges to Drug Makers
Aging Population – A Major Growth Driver

Table 4. Global Population Demographics (2017 & 2020P): Percentage Breakdown of Population by Age Group - Below 40 Years and 40 Years & Above (includes corresponding Graph/Chart)

Market Challenges
Lack of Clear Product Differentiation
Drug Formulation Fraught with Difficulties
Low Patient Compliance Limits Market Opportunities

3. NOTEWORTHY MARKET TRENDS

Companies Focus on New Formulations to Improve Results
Preference for Preservative-Free Artificial Tears on Rise
Management of Dry Eyes Post Eye Surgery Drives Demand for Artificial Tears

Table 5. Number of LASIK Surgeries in US and Europe (2015-2020) (in ‘000) (includes corresponding Graph/Chart)

Rise in Mobile Workforce and Number of Smartphone Addicts Spurs Growth Prospects

Table 6. Global Smartphone Adoption Rate (2013-2020) (includes corresponding Graph/Chart)

Table 7. Number of Mobile Phone Users Worldwide (2014-2020) (in Billions) (includes corresponding Graph/Chart)

An Upswing in Contact Lens Wearers Unfolds New Opportunities

Table 8. Penetration of Contact Lenses in Select Countries/Regions (2017) (includes corresponding Graph/Chart)

Manufacturers Focus Efforts on Formulating the Right Artificial Tears for Contact Lens Wearers
Environmental Factors Play an Important Role
Nanotechnology and Other Innovative Delivery Techniques Gain Attention in DES Treatment
Direct-to-Customer Promotions: A Primary Marketing Strategy

4. DRY EYE SYNDROME – AN OVERVIEW

Dry Eye – A Common Ophthalmic Condition
Causes of Dry Eyes
Diagnosis of Dry Eye Syndrome
Multi-Factorial Nature of Dry Eye Poses Challenge to Drug Makers
Bridging Chasm between Diagnosis and Treatment of Dry Eye Syndrome
Product Options for Dry Eye Syndrome: Breakdown by Palliative Therapies and Targeted Therapies
KCS Inflammation Cycle
Common Symptoms of KCS
Risk Factors for Dry Eye Disease
Impact of Dry Eye Syndrome on Routine Daily Life Activities: Ranking based on Intensity of Impact Felt by Patients
Novel Approaches to Revolutionize Dry Eye Therapy
Anti-Inflammatory Drugs
Mucin Secretagogues
Hormonal Therapies
Omega-3 Drugs
Muco-Mimetics
Barrier-function Drugs

5. PRODUCT OVERVIEW

Artificial Tears – An Overview
Types of Artificial Tears
Artificial Tears Usage and Dosage
Evolution of Artificial Tears
First-Generation
Second-Generation
Third-Generation
Fourth-Generation
Alternate Treatment Methods

6. COMPETITIVE LANDSCAPE

Leading Players

Table 9. Leading Players in the Global Artificial Tears Market (2016): Percentage Share Breakdown of Sales by Company (includes corresponding Graph/Chart)

Artificial Tears for Dry Eye Syndrome-Single-use (Unit dose)
Artificial Tears for Dry Eye Syndrome-Multi dose
6.1 Focus on Select Global Players
Allergan plc (Ireland)
Akorn, Inc. (USA)
Bausch & Lomb Incorporated (USA)
Johnson & Johnson (USA)
Novartis International AG (Switzerland)
Alcon, Inc. (Switzerland)
Santen Pharmaceuticals Co, Ltd. (Japan)
6.2 Product Launches/Approvals/Introductions
Alcon Launches Systane Complete
Grafton Optical Adds I-LID ’N LASH Ocular Hygiene Product Line from I-MED Pharma
Allergan Introduces TrueTear (Allergan)
Novaliq Introduces NovaTears
Allergan Launches REFRESH OPTIVE MEGA-3
Thea Pharmaceuticals Introduces Thealoz Duo
6.3 Recent Industry Activity
Novartis to Spinoff Alcon
I-MED Pharma Signs Distribution Agreement with IMEX
Novartis to In-license ECF843 for Ophthalmic Indications
Johnson & Johnson Acquires Abbott Medical Optics

7. GLOBAL MARKET PERSPECTIVE

Table 10. World Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)

Table 11. World Historic Review for Artificial Tears by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)

Table 12. World 14-Year Perspective for Artificial Tears by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

8. REGIONAL MARKET PERSPECTIVE

8.1 The United States
A. Market Analysis
Current and Future Analysis

Table 13. Prevalence of Dry Eye Disease in the US (2017): Percentage Breakdown by Dry Eye Category (includes corresponding Graph/Chart)

Demographics Remain an Important Growth Driver

Table 14. US Population Demographics (2015-2030): Percentage Breakdown of Population by Age Group (includes corresponding Graph/Chart)

Table 15. Prevalence of Dry Eye Condition in the US (2014) (includes corresponding Graph/Chart)

Table 16. US Women Population (2015-2030): Percentage Breakdown of Population by Age Group (includes corresponding Graph/Chart)

Lifestyle and Environmental Factors – A Major Reason Behind Rise in Eye Care Market
Air Pollution Bears Close Association with DES Risk
B. Market Analytics

Table 17. US Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)

Table 18. US Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)

8.2 Canada
Market Analysis

Table 19. Canadian Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)

Table 20. Canadian Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)

8.3 Japan
A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 21. Japanese Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)

Table 22. Japanese Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)

8.4 Europe
A. Market Analysis
Current and Future Analysis
Market Overview
Overview of Select Markets
Germany
Italy

UK

Russia
B. Market Analytics

Table 23. European Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)

Table 24. European Historic Review for Artificial Tears by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)

Table 25. European 14-Year Perspective for Artificial Tears by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

8.5 Asia-Pacific
A. Market Analysis
Current and Future Analysis
Focus on Select Regional Markets
Australia
China
India
B. Market Analytics

Table 26. Asia-Pacific Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)

Table 27. Asia-Pacific Historic Review for Artificial Tears by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)

Table 28. Asia-Pacific 14-Year Perspective for Artificial Tears by Geographic Region/Country - Percentage Breakdown of Dollar Sales for China, India, and Rest of Asia-Pacific Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

8.6 Latin America
A. Market Analysis
Current and Future Analysis
B. Market Analytics

Table 29. Latin American Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)

Table 30. Latin American Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)

8.7 Rest of World
Market Analysis

Table 31. Rest of World Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)

Table 32. Rest of World Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)

9. COMPANY PROFILES

Total Companies Profiled: 49 (including Divisions/Subsidiaries - 54)
The United States (19)
Canada (3)
Japan (3)
Europe (14)
  France (1)
  Germany (3)
  The United Kingdom (3)
  Italy (1)
  Spain (1)
  Rest of Europe (9)
Asia-Pacific (Excluding Japan) (12)
Middle East (1)
Africa (2)